Pharmacy practice in hospital settings in GCC countries: Pharmacists' medication therapy monitoring activities.
| Autor: | Al-Jedai AH; Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia.; Colleges of Medicine and Pharmacy, Al-Faisal University, Riyadh, Saudi Arabia., Mayet AY; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box: 2457, Riyadh 11451, Saudi Arabia., Khurshid F; Department of Pharmacy, Institute of Biomedical Education and Research, Mangalayatan University, Aligarh 202145, India., Alsultan MS; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box: 2457, Riyadh 11451, Saudi Arabia. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2024 Feb; Vol. 32 (2), pp. 101952. Date of Electronic Publication: 2024 Jan 04. |
| DOI: | 10.1016/j.jsps.2024.101952 |
| Abstrakt: | Purpose: Our study aims to provide an overview of medication therapy monitoring practices carried out by pharmacists in hospitals across the Gulf Cooperation Council (GCC) countries. Methods: This is a cross-sectional questionnaire-based study of hospitals located in the GCC. Questions were adopted from the American Society of Health-System Pharmacists (ASHP) national survey. Frequency analyses were used to examine the number and percentages of specific responses to the survey questions. Results: A total of 64 hospitals participated in this survey, reflecting an overall response rate of 52.0%. Almost half of participating hospitals (48.4%) were from Saudi Arabia. Among the 64 participating hospitals, 54.7% monitored their patients daily, 40.6% assigned pharmacists to patient care units for at least eight hours per day, and 42.2% held pharmacists accountable for medication-related outcomes. Moreover, the criteria used to identify patients requiring monitoring, 35.9% relied on the list of high-risk medications, 26.5% relied on specific medical services, 21.9% relied on directions from the hospital committee, and 17.2% relied on lab abnormalities. The most frequently utilized method for monitoring adverse drug events (ADEs) was through notifications from nurses or physicians, observed in 60.9% of participating hospitals. Conclusion: The survey emphasizes the need for hospitals in the GCC to promote increased pharmacist accountability for medication-related outcomes, explore technological solutions to enhance monitoring efficiency and extend the presence of pharmacists in patient care units beyond the current level. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2024 The Authors. Published by Elsevier B.V. on behalf of King Saud University.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|